These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9466538)

  • 1. Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults.
    Falsey AR; Walsh EE
    J Infect Dis; 1998 Feb; 177(2):463-6. PubMed ID: 9466538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults.
    Walsh EE; Falsey AR
    J Infect Dis; 2004 Jul; 190(2):373-8. PubMed ID: 15216475
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum neutralizing antibody titers of seropositive chimpanzees immunized with vaccines coformulated with natural fusion and attachment proteins of respiratory syncytial virus.
    Hancock GE; Smith JD; Heers KM
    J Infect Dis; 2000 May; 181(5):1768-71. PubMed ID: 10823781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults.
    Ye X; Iwuchukwu OP; Avadhanula V; Aideyan LO; McBride TJ; Ferlic-Stark LL; Patel KD; Piedra FA; Shah DP; Chemaly RF; Piedra PA
    Front Immunol; 2019; 10():706. PubMed ID: 30984206
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia.
    Groothuis JR; King SJ; Hogerman DA; Paradiso PR; Simoes EA
    J Infect Dis; 1998 Feb; 177(2):467-9. PubMed ID: 9466539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of respiratory syncytial virus humoral immunity and response to infection in young and elderly adults.
    Falsey AR; Walsh EE; Looney RJ; Kolassa JE; Formica MA; Criddle MC; Hall WJ
    J Med Virol; 1999 Oct; 59(2):221-6. PubMed ID: 10459160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin.
    Siber GR; Leombruno D; Leszczynski J; McIver J; Bodkin D; Gonin R; Thompson CM; Walsh EE; Piedra PA; Hemming VG
    J Infect Dis; 1994 Jun; 169(6):1368-73. PubMed ID: 8195619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus specific serum antibodies in infants under six months of age: limited serological response upon infection.
    Brandenburg AH; Groen J; van Steensel-Moll HA; Claas EC; Rothbarth PH; Neijens HJ; Osterhaus AD
    J Med Virol; 1997 May; 52(1):97-104. PubMed ID: 9131465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies.
    Piedra PA; Jewell AM; Cron SG; Atmar RL; Glezen WP
    Vaccine; 2003 Jul; 21(24):3479-82. PubMed ID: 12850364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis.
    Piedra PA; Grace S; Jewell A; Spinelli S; Bunting D; Hogerman DA; Malinoski F; Hiatt PW
    Pediatr Infect Dis J; 1996 Jan; 15(1):23-31. PubMed ID: 8684872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory syncytial virus infection in older persons.
    Falsey AR
    Vaccine; 1998 Nov; 16(18):1775-8. PubMed ID: 9778756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of respiratory syncytial virus (RSV) antigen in the lungs of guinea pigs 6 weeks after experimental infection and despite of the production of neutralizing antibodies.
    Streckert HJ; Philippou S; Riedel F
    Arch Virol; 1996; 141(3-4):401-10. PubMed ID: 8645083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of human antibodies against linear antigenic and immunogenic regions of respiratory syncytial virus (RSV) nucleocapsid and phospho-proteins shows the site-directed characteristics.
    Leonova IV; Leonov SV; Waris M; Russi JC; Grandien M; Norrby E
    J Clin Virol; 1998 Aug; 11(2):137-47. PubMed ID: 9785215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique.
    Roca A; Abacassamo F; Loscertales MP; Quintó L; Gómez-Olivé X; Fenwick F; Saiz JC; Toms G; Alonso PL
    J Med Virol; 2002 Aug; 67(4):616-23. PubMed ID: 12116014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A direct comparison of the activities of two humanized respiratory syncytial virus monoclonal antibodies: MEDI-493 and RSHZl9.
    Johnson S; Griego SD; Pfarr DS; Doyle ML; Woods R; Carlin D; Prince GA; Koenig S; Young JF; Dillon SB
    J Infect Dis; 1999 Jul; 180(1):35-40. PubMed ID: 10353858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response and avidity of respiratory syncytial virus-specific total IgG, IgG1, and IgG3 in young children.
    Freitas GR; Silva DA; Yokosawa J; Paula NT; Costa LF; Carneiro BM; Ribeiro LZ; Oliveira TF; Mineo JR; Queiróz DA
    J Med Virol; 2011 Oct; 83(10):1826-33. PubMed ID: 21837801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of neutralizing antibodies in adults with community-acquired pneumonia by respiratory syncytial virus.
    Luchsinger V; Piedra PA; Ruiz M; Zunino E; Martínez MA; Machado C; Fasce R; Ulloa MT; Fink MC; Lara P; Avendaño LF
    Clin Infect Dis; 2012 Apr; 54(7):905-12. PubMed ID: 22238168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age related differences in humoral immune response to respiratory syncytial virus infection in adults.
    Walsh EE; Falsey AR
    J Med Virol; 2004 Jun; 73(2):295-9. PubMed ID: 15122807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.